Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090060 · ClinicalTrials.gov registry record · NA
The Prevent Anal Cancer Palpation Study
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 718
- Enrollment target
NCT04090060 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 718 participants.
The verdict
NCT04090060, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 718 participants
- Enrollment target
Study Summary
Anal cancer is a common cancer among men having sex with men (MSM). We will investigate increasing detection of anal canal tumors through self- or partner-palpation of the anal canal among MSM and trans persons. This study in Houston and Chicago will recruit a sample of 100 couples (i.e., 200 partners) and 600 single persons (one-half HIV-positive), aged ≥ 25 years, who will be taught to perform an ASE or ACE. After performing the exam in private, the individual's ASE and partner's ACE will then be compared with a clinician's DARE. The assessment will be done at each of two visits, spaced 6-months apart. One-half of persons will be randomized to a practice condition to assess how practice affects accuracy and retention of exam procedure. Our hypothesis is that both ASE and ACE at visit 1 will have ≥70% sensitivity and ≥90% specificity using the clinician DARE as the gold standard at each of two visits.
Interventions
- BEHAVIORAL Control Arm
- BEHAVIORAL Practice Self-/Companion Exams
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 718 participants |
| Start Date | 2020-01-17 |
| Est. Completion | 2023-06-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04090060
The ClinicalTrials.gov registry entry for NCT04090060 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 718 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Arm is the first listed.
NCT04090060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04090060 about?
NCT04090060 is a clinical study titled "The Prevent Anal Cancer Palpation Study". Anal cancer is a common cancer among men having sex with men (MSM). We will investigate increasing detection of anal canal tumors through self- or partner-palpation of the anal canal among MSM and trans persons. This study in Houston and Chicago will recruit a sample of 100 couples (i.e., 200 partne...
What is the current status of trial NCT04090060?
This trial is currently completed. It is a NA study. The enrollment target is 718 participants. The study started on 2020-01-17. Estimated completion is 2023-06-10.
What interventions are being tested in trial NCT04090060?
The interventions under investigation include: Control Arm (BEHAVIORAL), Practice Self-/Companion Exams (BEHAVIORAL).
Who is sponsoring clinical trial NCT04090060?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.